Now showing items 1-3 of 3

    • FGF23/FGFR4-mediated left ventricular hypertrophy is reversible. 

      Grabner, Alexander; Wolf, Myles; Schramm, Karla; Silswal, Neerupma; Hendrix, Matt; Yanucil, Christopher; Czaya, Brian; ... (14 authors) (Scientific reports, 2017-05-16)
      Fibroblast growth factor (FGF) 23 is a phosphaturic hormone that directly targets cardiac myocytes via FGF receptor (FGFR) 4 thereby inducing hypertrophic myocyte growth and the development of left ventricular hypertrophy ...
    • Heart rate is associated with progression of atrial fibrillation, independent of rhythm. 

      Chang, P; Fonarow, GC; Freeman, JV; Gersh, Bernard John; Holmqvist, Fredrik Nils; Kim, S; Kowey, Peter R; ... (15 authors) (Heart, 2015-06)
      OBJECTIVE: Atrial fibrillation (AF) often progresses from paroxysmal or persistent to more sustained forms, but the rate and predictors of AF progression in clinical practice are not well described. METHODS: Using the Outcomes ...
    • Ventricular conduction and long-term heart failure outcomes and mortality in African Americans: insights from the Jackson Heart Study. 

      Ahmad, T; Choudhary, G; Curtis, Lesley H; DeVore, Adam David; Dunlay, SM; Eapen, Zubin John; Greiner, Melissa A; ... (14 authors) (Circ Heart Fail, 2015-03)
      BACKGROUND: QRS prolongation is associated with adverse outcomes in mostly white populations, but its clinical significance is not well established for other groups. We investigated the association between QRS duration and ...